Ruh Sağlığı ve Hastalıkları/Konferans Öğesi Koleksiyonu
Bu koleksiyon için kalıcı URI
Güncel Gönderiler
Öğe Long-acting injectable paliperidone as maintenance treatment for bipolar disorders(ELSEVIER, 2019) Altınbaş, K.; Akıtan, B.; Yavuz, E.[Abstract not Available]Öğe Evaluation of the recurrence rates after the first manic episode: one year follow-up study(ELSEVIER SCIENCE BV, 2019) Erbasan, V.; Aydın, M.; Selvi, Y.; Altınbaş, K.[Abstract not Available]Öğe Evaluation of suicide attempt by using medicines and chemicals(ELSEVIER SCIENCE BV, 2019) Kavak, G.[Abstract not Available]Öğe Comparison of the affective lability and temperament characteristics between depressive patients with and without mixed features(ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER, 2019) Altınbaş, Kürşat; Taş, Halil İbrahim[Abstract not Available]Öğe Are cardiovascular disease risk factors affected by antipsychotics in patients with schizophrenia? What QRISK-3 points?(ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER, 2019) Aydın, Memduha; Altınbaş, Kürşat; Bozkurt, Hazan Tomar[Abstract not Available]Öğe Varenicline-Induced Psychotic Depressive Episode in a Patient with Bipolar Disorder(WILEY-BLACKWELL, 2012) Annagür, Bilge Burçak; Bez, YasinVarenicline is a relatively novel medication for smoking cessation. Increased neuropsychiatric symptoms have been reported with its use and it is listed among drugs with a black box warning. History of a psychiatric diagnosis is suggested to be a vulnerability factor for the development of some psychiatric side effects with its use. However, empirical evidence to support this point is very limited. Here, we report the case of a bipolar patient who developed a depressive episode with psychotic features immediately after varenicline use. Clinicians should be careful about the varenicline-induced neuropsychiatric effects. Healthcare professionals can provide an important role in helping to prevent and manage worsening psychiatric symptoms.
